The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 7 Tips That Dermatologists Want Rheumatologists to Know

7 Tips That Dermatologists Want Rheumatologists to Know

November 2, 2014 • By Vanessa Caceres

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Dermatologists may diagnose and treat patients with conditions that span a variety of specialties, but rheumatology is at the top of the crossover list, says dermatologist Mark Lebwohl, MD, professor and system chair, dermatology, Mount Sinai Medical Center, New York.

You Might Also Like
  • Skin Disease in Rheumatology Patients Should Prompt Collaboration with Dermatologists
  • What Rheumatologists Wish Their Colleagues Knew: Managing Skin Disease & Comorbidities
  • Dermatology Case Answer
Explore This Issue
November 2014
Also By This Author
  • Lupus Immunology Trends Provide Insights for Rheumatologists

Rheumatologists and dermatologists usually don’t hesitate to refer to each other as needed, says rheumatologist Kelly Weselman, MD, WellStar Medical Group, Smyrna, Ga. “There’s no reluctance to think about each other. It’s always nice to keep the lines of communication open,” she says.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The crossover reaches into three main areas, says rheumatologist Susan M. Goodman, MD, an associate attending physician at the Hospital for Special Surgery in New York. First, there’s systemic rheumatic disease with major skin manifestations, such as systemic lupus erythematosus (SLE), dermatomyositis and scleroderma. Seventy percent of SLE patients will have a rash at some point, Dr. Goodman says. The other conditions can lead a patient to develop inflammatory skin features.

Next, there are inflammatory joint diseases, in which psoriatic arthritis emerges as the most prominent. “As many as 30% of patients attending a psoriasis clinic have evidence of psoriatic arthritis when systematically examined. In these conditions where systemic features may be prognostically significant, a collaborative approach is optimal,” Dr. Goodman says. There’s also rheumatoid arthritis, in which leg ulcers or splinter hemorrhages can indicate vasculitis as a complication of the disease, Dr. Goodman says.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Finally, infections can present with a rash that is a complication from a disordered immune system of the rheumatic diseases or because of the immunosuppressant medications used to treat these illnesses, Dr. Goodman added.

Rheumatologists and dermatologists also work collaboratively on skin biopsies, says rheumatologist Alan Baer, MD, director, Johns Hopkins Jerome L. Greene Sjögren’s Syndrome Center, Johns Hopkins University School of Medicine, Baltimore. “Skin biopsies may be required for the definitive diagnosis of certain skin eruptions seen in the context of rheumatic disease, and these are often done by the dermatologist, although they can be done by rheumatologists if they have the expertise,” he says.

The crossover between rheumatology and dermatology doesn’t stop with patient care, Dr. Lebwohl says. The two specialties even align from time to time on regulatory agendas. “It’s smart for us to work together on things like HIPAA, the Sustainable Growth Rate fix and other political issues,” he says.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Even with the natural collaboration, there are still pearls rheumatologists can follow to improve care when patients have dermatological symptoms.

7 Tips from Dermatologists

1. Aim for collaborative care—and education—when possible. Dermatologist and rheumatologist Joseph F. Merola, MD, Brigham and Women’s Hospital, and instructor, Harvard Medical School, Boston, has heard of more academic medical centers combining rheumatology and dermatology care in one area, enabling patients to get one-stop, holistic care, which he says that patients love. “It also opens up a lot of other opportunities for crosspollination between the fields,” he says.

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, Education & Training, Professional Topics, Scleroderma, SLE (Lupus) Tagged With: Biologics, conditions, Dermatology, Diagnosis, patient care, prednisone, Psoriatic Arthritis, rheumatologist, Scleroderma, Steroids, Systemic lupus erythematosus, Treatment, VasculitisIssue: November 2014

You Might Also Like:
  • Skin Disease in Rheumatology Patients Should Prompt Collaboration with Dermatologists
  • What Rheumatologists Wish Their Colleagues Knew: Managing Skin Disease & Comorbidities
  • Dermatology Case Answer
  • Dermatology Consults May Cut Hospital Stays, Readmissions

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)